W06 Ricerca farmaco
Stampa
W06 Ricerca farmaco
A phase 3 Multicenter Open-label Study of Brigatinib (AP26113) versus Crizotinib in Patients with ALK-positive Advanced Lung Cancer
2015-003447-19
ARIAD Pharmaceuticals Inc. un’azienda interamente controllata da Takeda Pharmaceutical Company Limited
AP26113
28-11-2016
29-11-2016
8.264,00
2.529,00
10.793,00
Pincipal investigators
Oncologia di Ravenna
Federico Cappuzzo